tadalafil has been researched along with testosterone enanthate in 2 studies
Studies (tadalafil) | Trials (tadalafil) | Recent Studies (post-2010) (tadalafil) | Studies (testosterone enanthate) | Trials (testosterone enanthate) | Recent Studies (post-2010) (testosterone enanthate) |
---|---|---|---|---|---|
1,742 | 392 | 1,089 | 570 | 143 | 116 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bae, JH; Kim, JJ; Kim, JW; Moon, DG; Oh, MM; Park, JY; Park, MG | 1 |
Abbaszadeh Hasiri, M; Ahrari Khafi, MS; Dearakhshandeh, N; Golchin-Rad, K; Mogheiseh, A; Nazifi, S | 1 |
1 trial(s) available for tadalafil and testosterone enanthate
Article | Year |
---|---|
Changes in the oxidative stress factors and inflammatory proteins following the treatment of BPH-induced dogs with an anti-proliferative agent called tadalafil.
Topics: Androgens; Animals; Contraceptive Agents, Hormonal; Dog Diseases; Dogs; Estradiol; Gene Expression Regulation; Inflammation; Male; Oxidative Stress; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Tadalafil; Testosterone | 2019 |
1 other study(ies) available for tadalafil and testosterone enanthate
Article | Year |
---|---|
Combination therapy of testosterone enanthate and tadalafil on PDE5 inhibitor non-reponders with severe and intermediate testosterone deficiency.
Topics: Adult; Aged; Carbolines; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Retreatment; Tadalafil; Testosterone; Treatment Outcome; Vasodilator Agents | 2013 |